Institute of Biotechnology, Federal University of Uberlândia, Uberlândia, Brazil.
Eur Rev Med Pharmacol Sci. 2022 Jul;26(13):4828-4839. doi: 10.26355/eurrev_202207_29208.
The use of chicken embryos (CEs) as an in vivo experimental model for different pharmaceutical purposes is not a novelty. However, in recent years, the number of reports employing CE to evaluate several parameters, such as the toxicity and efficacy of drugs and/or nanosystems, has increased. Therefore, this review discusses the relevance of CE for drug testing, emphasizing the inoculation routes and the embryonic stages. The challenges to be overcome, as well as some practical recommendations to allow CE to be more explored as a promising in vivo model in drug analyses, are also highlighted.
鸡胚(CEs)作为一种用于不同药物用途的体内实验模型,并不是什么新鲜事。然而,近年来,利用 CE 评估药物和/或纳米系统的毒性和疗效等多个参数的报告数量有所增加。因此,本综述讨论了 CE 在药物测试中的相关性,重点介绍了接种途径和胚胎阶段。还强调了需要克服的挑战,以及一些实用建议,以允许 CE 更广泛地作为药物分析中一种有前途的体内模型进行探索。